WST R&D to Revenue
West Pharmaceutical Services · R&D to Revenue
WST R&D to Revenue
Latest reported2.26%period ending
WST Quarterly R&D/Revenue (0.00% → 2.26%)
Latest values, visible window
High-resolution chart · PNG
WST r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 2.2584% | |
| 1.87% | |
| 2.7081% | |
| 2.1261% | |
| 2.4928% | |
| 2.3346% | |
| 2.4716% | |
| 2.0752% | |
| 2.4929% | |
| 2.5313% | |
| 2.5133% | |
| 2.194% | |
| 2.1877% | |
| 2.3886% | |
| 2.2445% | |
| 1.9814% | |
| 1.8663% | |
| 2.0286% | |
| 1.8793% | |
| 1.8539% | |
| 1.9058% | |
| 1.8182% | |
| 2.223% | |
| 2.2798% | |
| 2.0497% | |
| 2.1779% | |
| 2.1469% | |
| 2.0404% | |
| 2.0452% | |
| 2.2107% | |
| 2.3206% | |
| 2.3396% | |
| 2.4118% | |
| 2.3066% | |
| 2.3317% | |
| 2.283% | |
| 2.5138% | |
| 2.656% | |
| 2.5118% | |
| 2.3892% | |
| 2.268% | |
| 2.596% | |
| 2.7801% | |
| 2.4673% | |
| 2.2519% | |
| 2.2328% | |
| 2.2298% | |
| 2.6974% | |
| 2.6837% | |
| 2.8835% | |
| 2.8305% | |
| 2.8087% | |
| 2.7576% | |
| 2.6812% | |
| 2.675% | |
| 2.6991% | |
| 2.5246% | |
| 2.6241% | |
| 2.4374% | |
| 2.6226% | |
| 2.3709% | |
| 2.3358% | |
| 2.4928% | |
| 2.1739% | |
| 2.0227% | |
| 1.9658% | |
| 1.9768% | |
| 1.9699% | |
| 1.8008% | |
| 1.7739% | |
| 1.5931% | |
| 1.7955% | |
| 1.7544% | |
| 1.9948% | |
| 1.7962% | |
| 1.6893% | |
| 1.441% | |
| 1.3975% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |